ProBio, a contract development and manufacturing organization (CDMO) specializing in gene and cell therapy, has launched cGMP ...

CureVac and GSK will receive $740 million and single-digit royalties on COVID-19 vaccine sales in the U.S. going forward.

Intas Pharmaceuticals in collaboration with its global Accord brand subsidiaries, has acquired UDENYCA (pegfilgrastim-cbqv) ...

As part of Sanner’s strategic transformation into a Contract Development and Manufacturing Organization (CDMO) for medical ...

Advarra, a provider of clinical research technology, expanded its Study Collaboration, a study startup technology designed to ...

Marken's Mike Bartone, VP of Global Cold Chain Solutions Management, on scaling temperature-controlled precision logistics, ...

Emerging therapies targeting GD2, a marker highly expressed in neuroblastoma, offer tremendous promise. FDA-approved ...

Founded in 1997, VEG built its reputation through its deep engineering expertise across a range of CQV services. The ...

Minghui Pharmaceutical ( Minghui ), a late-stage clinical biopharmaceutical company, announced the closing of a $131 million ...

The expansion increases output, enhancing Axplora’s ability to meet growing global demand for high-value pharmaceutical ...

To layoff 5,000 employees by the end of the year; aims to reduce operating expenses by approximately $1.5 billion by 2027.

David King of Samsung Biologics shares insights on market demand and the technologies and capabilities needed to support ...